SJ Berwin has completed its first deal for Israeli drug company Neurim Pharmaceuticals, advising on the licensing of a new treatment for insomnia.
October 10, 2007 at 09:57 PM
1 minute read
The original version of this story was published on Legalweek
SJ Berwin has completed its first deal for Israeli drug company Neurim Pharmaceuticals, advising on the licensing of a new treatment for insomnia.
The City law firm, which first started working with Neurim last year, has advised the company on the licensing of a new melatonin-based product for severe insomnia to Danish research group H Lundbeck.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
